Blood Flow Insights that Matter
Blood Flow Insights that Matter

Blood Flow Insights that Matter

Non-invasive perfusion data that powers vascular care

ElfiTech advances vascular care with a non-invasive system that continuously delivers unique, reliable perfusion data, providing real-time decision support for tissue perfusion management and vascular research

Advancing PAD Care and Beyond
Advancing PAD Care and Beyond

Advancing PAD Care and Beyond

Validated perfusion metrics for peripheral artery disease management

ElfiTech advances vascular care with a non-invasive system that continuously delivers unique, reliable perfusion data, providing real-time decision supportfor tissue perfusion management and vascular research

Elfitech is powered by proprietary

technology

Simple

  • Non-invasive
  • Miniaturized sensor package
  • Integrates with any
    monitoring system

Versatile

  • Works on all skin pigmentation
  • Adheres to any body site
  • Unaffected by ambient light

Informative

  • Clinically validated perfusion data
  • Deeper insights through patented algorithms and AI assisted tools
  • Continuous & real-time trends

PAD is a large and growing market

Peripheral artery disease (PAD) impairs limb blood flow, making objective perfusion testing pivotal for better Diagnosis, earlier interventions, and lower complication costs

26M

diagnosed patients in the US1

9% CAGR

~400K

interventions per year in the US2

15-30%

post – operative complication rate3

~6.3B

total complication cost in the US4

Advancing care across the PAD continuum

The same validated engine powers the FDA-cleared Faro™ Research Kit and our integrated PAD product suite. Kuro™ enables fast, affordable early PAD diagnosis, while Azora™ delivers continuous peri-operative monitoring from the OR through recovery and home care. Together, these solutions cover the full PAD continuum – from cutting-edge research to early risk detection, ongoing monitoring, and informed clinical decision-making.

Faro™


Research

The Faro™ research kit accelerates vascular discovery with a plug-and-play, non-invasive mDLS sensor that attaches to any body site, unaffected by ambient light and motion noise, and streams validated perfusion waveforms, giving scientists high-quality blood-flow insights in any lab or pre-clinical model

Kuro™


Diagnosis

Kuro™ delivers rapid, point-of-care PAD screening in primary care with a single, non-invasive 5-minute test, providing reproducible results across all skin phototypes. It integrates seamlessly into routine consultations, enabling early detection, risk stratification, and timely referral for vascular evaluation.

Azora™


Monitoring

Intra-operation | Post-operation | Home care

Azora™ delivers continuous, real-time perioperative monitoring of peripheral perfusion during and after endovascular interventions, streaming validated indices to any standard monitor to enable early intervention, prevent complications, improve outcomes, and reduce costs.

Our Team

Erez Herman, MSc, MBA

Chief Executive Officer

Roy Meidan, MD, MBA

Head of Product / Chief Medical Officer

Ilya Fine, PhD

Founder & Chief Scientific Officer

Sam Hirschman, CPA

Chief Financial Officer

Sapir Fajerzstein, MSc

Senior Algorithm Engineer

Nimrod Elstein, BSc

Director of R&D

Alex Buchman, BSc

Biomedical Engineer

Lior Keller, BSc

Product Manager

Miri Genkin, MSc

Finance & Operations Manager

Advisors

Angad Beri, MBA

Growth Strategy Advisor. Former Director of Corporate Dev at Baxter Healthcare and Thermo Fisher

Professor Irwin K.M. Reiss, MD, PhD

Head of Neonatology at Erasmus MC – Sophia Children’s Hospital. Specialist in neonatal care, pulmonary development, and intensive care research

Let’s Build the Future of PAD Care & Beyond

With over a decade of deep tech development behind us, we are now bringing our core innovation to the clinic.

Join us at this pivotal moment to create validated, scalable solutions for early diagnosis, monitoring, and intervention in PAD and beyond.

Elfitech is actively seeking strategic partners to co-develop next-generation vascular solutions – starting with PAD. Our non-invasive tissue perfusion management technology is ready to be integrated into clinical tools, surgical workflows, and vascular research.

Contact Us

info@elfi-tech.com

Regulatory status: The Elfor-L clinical research system (Faro) has received FDA 510(k) clearance for measuring microvascular perfusion in human skin. It is intended for clinical and pre-clinical research applications. Elfi-Tech is ISO 13485 & 9001 certified.